These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28463820)

  • 1. Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey.
    Mi W; Zhang S; Liu Q; Yang F; Wang Y; Li T; Mei Q; He H; Chen Z; Su Z; Liu T; Xie S; Tan Q; Zhang J; Zhang C; Sang H; Chen W; Shi L; Li L; Shi Y; Guo L; Zhang H; Lu L
    Psychiatry Res; 2017 Jul; 253():401-406. PubMed ID: 28463820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.
    Sacchetti E; Valsecchi P; Tamussi E; Paulli L; Morigi R; Vita A
    Psychiatry Res; 2018 Dec; 270():357-364. PubMed ID: 30293014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
    Allen MH; Debanné M; Lazignac C; Adam E; Dickinson LM; Damsa C
    Am J Psychiatry; 2011 Apr; 168(4):395-9. PubMed ID: 21245085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.
    Citrome L; Du Y; Risinger R; Stankovic S; Claxton A; Zummo J; Bose A; Silverman BL; Ehrich EW
    Int Clin Psychopharmacol; 2016 Mar; 31(2):69-75. PubMed ID: 26517202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients.
    Huber CG; Lambert M; Naber D; Schacht A; Hundemer HP; Wagner TT; Schimmelmann BG
    Schizophr Res; 2008 Mar; 100(1-3):342-8. PubMed ID: 18255271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
    Bauer JØ; Stenborg D; Lodahl T; Mønsted MM
    Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder.
    Huber CG; Hochstrasser L; Meister K; Schimmelmann BG; Lambert M
    Schizophr Res; 2016 Aug; 175(1-3):198-203. PubMed ID: 27117676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-patient costs of agitation and containment in a mental health catchment area.
    Serrano-Blanco A; Rubio-Valera M; Aznar-Lou I; Baladón Higuera L; Gibert K; Gracia Canales A; Kaskens L; Ortiz JM; Salvador-Carulla L
    BMC Psychiatry; 2017 Jun; 17(1):212. PubMed ID: 28583103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia.
    Zhang XY; Al Jurdi RK; Zoghbi AW; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR
    J Psychiatr Res; 2013 Oct; 47(10):1370-5. PubMed ID: 23791457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and clinical correlates of restless legs syndrome in schizophrenia.
    Kang SG; Lee HJ; Jung SW; Cho SN; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1078-83. PubMed ID: 17459547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of aggression in hospitalized patients with schizophrenia in China: A meta-analysis.
    Zhou JS; Zhong BL; Xiang YT; Chen Q; Cao XL; Correll CU; Ungvari GS; Chiu HF; Lai KY; Wang XP
    Asia Pac Psychiatry; 2016 Mar; 8(1):60-9. PubMed ID: 26346165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analysis of the brief agitation rating scale in a large sample of norwegian nursing home patients.
    Sommer OH; Kirkevold O; Cvancarova M; Engedal K
    Dement Geriatr Cogn Disord; 2010; 29(1):55-60. PubMed ID: 20110701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior.
    Barzilay R; Lobel T; Krivoy A; Shlosberg D; Weizman A; Katz N
    Eur Psychiatry; 2016 Jan; 31():8-12. PubMed ID: 26657596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.